Heron Therapeutics
HRTX
#7401
Rank
A$0.54 B
Marketcap
$3.55
Share price
-3.25%
Change (1 day)
-15.42%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.86. In 2022 the company made an earnings per share (EPS) of -$2.75 an increase over its 2021 EPS that were of -$3.58.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-35.86%
2022-$2.75-23.11%
2021-$3.58-10%
2020-$3.97-0%
2019-$3.971.21%
2018-$3.93-32.7%
2017-$5.83-19.34%
2016-$7.2354.76%
2015-$4.671.73%
2014-$4.59-16.23%
2013-$5.4891.67%
2012-$2.86-31.45%
2011-$4.17-27.06%
2010-$5.72-43.75%
2009-$10.17-57.33%
2008-$23.85-82.92%
2007-$139.5920.61%
2006-$115.74175.76%
2005-$41.97-21.43%
2004-$53.42100%
2003-$26.71-38.24%
2002-$43.24161.54%
2001-$16.53-106.46%
2000$255.792051.55%
1999$11.89839.73%
1998$1.27-105.48%
1997-$23.10-88.16%
1996-$195.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.07-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.59 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.62 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA